| Previous close | 255.90 |
| Open | 259.10 |
| Bid | 259.35 x 20000 |
| Ask | 259.90 x 9000 |
| Day's range | 257.85 - 260.95 |
| 52-week range | 196.60 - 306.00 |
| Volume | |
| Avg. volume | 572 |
| Market cap | 140.545B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 22.15 |
| EPS (TTM) | 11.64 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 8.29 (3.24%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
- Yahoo Finance Video
Amgen, DraftKings, Live Nation: Trending tickers
Shares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology giant's revenue rose by 22% during the quarter. DraftKings (DKNG) also delivered a strong earnings report, surpassing analysts' estimates on both the top and bottom lines. Buoyed by this performance, the company raised its full-year outlook. Live Nation (LYV) topped revenue estimates in its first quarter earnings, although the company reported a loss of $0.53 per share. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
- GuruFocus.com
Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges
Insight into Amgen's Financial Performance and Future Outlook
- Reuters
UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22%
Amgen reported a slightly lower first-quarter profit on Thursday, citing higher operating and interest expense from its recent acquisition of rare disease drugmaker Horizon Therapeutics, partially offset by double-digit revenue growth. The biotechnology company's adjusted profit fell 1% to $3.96 per share, which still beat the average analyst estimate of $3.88 per share, according to LSEG data. The results were "essentially in-linish ... although not anything significant for the Street given that it is still early in the year," David Song, portfolio manager of the Tema Obesity & Cardiometabolic ETF said in an email.
